IP Library Granted Patent US 10,590,408
Granted Patent B2
US 10,590,408 · App. 15/429,760 · Granted Mar 17, 2020

Method and composition for biomolecule stabilization

Inventors: Peter James Tatnell (Cardiff, GB); Elizabeth Mary Ashman (Cardiff, GB)
Assignee: GE Healthcare UK Limited
C12N9/96C12N9/1252C12Q1/686C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,590,408
App. No.
15/429,760
Granted
Mar 17, 2020
Kind
B2
Abstract

The present invention relates to biomolecule stabilization to provide biomolecules, such as sensitive polymerases, in a convenient ready-to-go format. The invention provides a method and composition in which non-ionic surfactant or detergents of the polyoxyethylene cetyl ether family are used, preferably a Brij reagent or a combination of Brij reagents.

Claims (9)

1. A method for stabilizing biomolecules, comprising: treating a biomolecule with a lyophilisation mixture comprising non-ionic surfactant Brij-58 (polyoxyethylene-20-cetyl ether); dispensing said mixture into a receptacle; and freeze-drying said mixture.

2. The method according to claim 1 , wherein the mixture also comprises: a collapse temperature modifier selected from dextran, hydroxyethyl starch, Ficoll and gelatin; a bulking agent selected from a sugar or sugar alcohol, or amino acids; a stabilizing protein; and a buffering agent, preferably Tris HCl.

3. The method according to claim 2 , for stabilization of protein.

4. The method according to claim 3 , for stabilization of nucleic acid polymerase.

5. The method according to claim 4 , wherein said mixture is formed into beads, cakes, conical, flat or square structure depending on the shape of the receptacle into which the composition is dispensed into.

6. A stabilized biomolecule composition, comprising a biomolecule stabilized in a mixture comprising non-ionic surfactant Brij 58 (polyoxyethylene-20-cetyl ether).

7. The biomolecule composition according to claim 6 , stabilized in a mixture comprising 1-20% Ficoll, 5-25% Melezitose, 0.1-5% Brij 58, 0.1-10 mg/mL BSA; and 5-50 mM Tris-HCl pH 9.0.

8. The biomolecule composition according to claim 7 , wherein the stabilized biomolecule is a protein.

9. The biomolecule composition according to claim 8 , wherein the stabilized biomolecule is in freeze dried or liquid format.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2020
From: GE HEALTHCARE UK LIMITED
To: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
Reel/Frame 053653/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2017
From: TATNELL, PETER JAMES; ASHMAN, ELIZABETH MARY
To: GE HEALTHCARE UK LIMITED
Reel/Frame 041226/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2017
From: TATNELL, PETER JAMES; ASHMAN, ELIZABETH MARY
To: GE HEALTHCARE UK LIMITED
Reel/Frame 041227/0284 →